New York State Common Retirement Fund Neoleukin Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.92 - $2.25 $12,972 - $31,725	-14,100 Reduced 97.94%	296 $0
Q4 2021 Feb 02, 2022	SELL	$4.65 - $7.75 $89,633 - $149,389	-19,276 Reduced 57.25%	14,396 $69,000
Q3 2021 Nov 02, 2021	SELL	$6.05 - $9.66 $78,680 - $125,628	-13,005 Reduced 27.86%	33,672 $243,000
Q2 2021 Aug 02, 2021	SELL	$9.23 - $13.12 $45,033 - $64,012	-4,879 Reduced 9.46%	46,677 $431,000
Q4 2020 Feb 08, 2021	SELL	$10.17 - $14.56 $5,085 - $7,280	-500 Reduced 0.96%	51,556 $727,000
Q3 2020 Nov 05, 2020	BUY	$9.68 - $17.01 $16,030 - $28,168	1,656 Added 3.29%	52,056 $625,000
Q2 2020 Aug 07, 2020	BUY	$9.95 - $17.05 $501,479 - $859,320	50,400 New	50,400 $837,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.